Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used clinically to treat type 2 diabetes mellitus.
IC50&Target
GLP-1 receptor
体外研究
Liraglutide binds to the same receptors as does the endogenous metabolic hormone GLP-1. Liraglutide is an injectable drug for the treatment of type 2 diabetes, also can be used to treat obesity in adults with some related comorbidity. Liraglutide activated AMPK/SREBP1 pathway in oxLDL-stimulated Raw264.7 cells.
分子式
C172H265N43O51
分子量
3751.26
CAS号
204656-20-2
中文名称
利拉鲁肽
运输条件
Room temperature in continental US; may vary elsewhere.